Stability comes first
Currently, there are seven different approved GLP-1RAs on the market: liraglutide once daily, semaglutide once weekly, exenatide extended-release (ER) once weekly, dulaglutide once weekly, oral semaglutide once daily, exenatide twice daily, and lixisenatide once daily
Immunology 1987
PlexusDx's precision approach examines how your genetic predispositions in GLP-1 and glucose metabolism pathways may influence therapy selection and dosing, enabling more informed discussions with your healthcare provider
Vegan-Friendly Clinically proven ingredientsx Cruelty-free Palm oil free Free from artificial colours flavours INGREDIENTS Reduced Glutathione, Hyaluronic Acid, ALA, NAC, Reservatol, Vitamins A, C E
The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss after 72 weeks with respect to the percentage change in body weight and the proportion of participants achieving weight loss of 5% or greater